+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pain Management Therapeutics Market by Drug Class (Adjuvant Analgesics, Local Anesthetics, Neuropathic Pain Agents), Route Of Administration (Oral, Parenteral, Topical), Indication, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Pain Management Therapeutics Market by Drug Class (Adjuvant Analgesics, Local Anesthetics, Neuropathic Pain Agents), Route Of Administration (Oral, Parenteral, Topical), Indication, Distribution Channel, End User - Global Forecast 2025-2030- Product Image
Sale

Pain Management Therapeutics Market by Drug Class (Adjuvant Analgesics, Local Anesthetics, Neuropathic Pain Agents), Route Of Administration (Oral, Parenteral, Topical), Indication, Distribution Channel, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 198 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4896709
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Pain Management Therapeutics Market is undergoing significant transformation as healthcare providers, payers, and innovators respond to changing patient needs and regulatory requirements. Senior decision-makers are now focusing on strategies that promote effective, safe, and scalable pain care solutions across both established and emerging therapeutic modalities.

Market Snapshot: Pain Management Therapeutics Market Growth Overview

The Pain Management Therapeutics Market grew from USD 86.51 billion in 2024 to USD 90.67 billion in 2025. It is expected to expand at a CAGR of 4.76%, reaching USD 114.41 billion by 2030.

Scope & Segmentation

This comprehensive research covers a broad spectrum of market categories and stakeholder priorities:

  • Drug Class: Adjuvant analgesics, local anesthetics, anticonvulsants, antidepressants, nonsteroidal anti-inflammatory drugs (including Cox-2 inhibitors and traditional NSAIDs), and opioids (strong and weak).
  • Route of Administration: Oral, parenteral (intramuscular, intravenous, subcutaneous), topical, and transdermal.
  • Indication: Acute pain, cancer pain, chronic pain (sub-divided into low back pain, neuropathic chronic pain, osteoarthritis, rheumatoid arthritis), inflammatory pain, and neuropathic pain.
  • Distribution Channel: Offline and online channels, encompassing both in-hospital and direct-to-patient models.
  • End User: Ambulatory surgical centers, home care settings (hospice care, patient home), and hospitals (private and public).
  • Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (with key markets like United Kingdom, Germany, France, Russia, Saudi Arabia, South Africa, and others), and Asia-Pacific (China, India, Japan, Australia, South Korea, among others).
  • Technological Modalities: Non-opioid approaches, biologics, digital health integration, artificial intelligence, machine learning, and advanced drug delivery mechanisms.

Pain Management Therapeutics Market: Key Takeaways

  • Industry leaders are prioritizing development of targeted and non-opioid analgesics to address demands for improved patient safety and regulatory compliance.
  • Advances in genetic profiling and machine learning are facilitating more precise pain management, allowing for adaptive dosing and enhanced monitoring of patient outcomes.
  • Healthcare providers are integrating digital health solutions to increase patient engagement, personalize treatment, and generate real-world evidence supporting payer decisions.
  • Adoption of alternative delivery systems, such as topical and transdermal formats, is gaining momentum among patients seeking convenience and reduced systemic exposure.
  • Regional differences in reimbursement frameworks, regulatory scrutiny, and cost containment are prompting manufacturers to utilize flexible pricing and localized partnerships.
  • Strategic collaborations between pharmaceutical firms and biotech innovators are accelerating portfolio diversification and expanding access to advanced therapeutic options.

Tariff Impact on Supply Chains

Anticipated tariff adjustments in 2025 are set to increase import duties on active pharmaceutical ingredients and finished products, elevating input costs for manufacturers that depend on cross-border sourcing. These shifts will affect distribution networks, potentially changing procurement and pricing strategies within care facilities. Organizations are actively exploring nearshoring, domestic production alliances, and adjusted logistics to maintain cost efficiency and mitigate disruption.

Methodology & Data Sources

This research utilizes a combined qualitative and quantitative approach, integrating interviews with industry experts, primary decision-makers, and supply chain executives to capture firsthand perspectives. Secondary analysis includes peer-reviewed literature, regulatory data, clinical trial outcomes, and proprietary market intelligence, ensuring insights are robust and reproducible.

Why This Report Matters

  • Enables strategic planning by mapping the interplay between regulatory trends, patient needs, and emerging technologies in the pain management therapeutics market.
  • Equips leaders with actionable recommendations to enhance operational resilience, optimize therapeutic portfolios, and align with shifting policy landscapes.
  • Supports market entry and growth decisions across diverse regions by providing clear segmentation, competitive intelligence, and assessment of supply chain challenges.

Conclusion

In a rapidly changing landscape, aligning innovation with regulatory and patient imperatives is essential for success. Identifying opportunities across technologies, segments, and geographies equips organizations to navigate complexity and capture long-term value in pain management therapeutics.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid adoption of virtual reality based therapies for chronic neuropathic pain management
5.2. Integration of wearable biosensing patches for continuous postoperative pain monitoring
5.3. Development of personalized gene therapy approaches targeting inflammatory pain pathways
5.4. Increasing use of digital health platforms to deliver cognitive behavioral therapy for pain
5.5. Growth in minimally invasive focused ultrasound applications for musculoskeletal pain relief
5.6. Surge in approval of long acting non opioid injectable formulations for osteoarthritis pain
5.7. Emergence of cannabinoid receptor modulators designed for targeted neuropathic pain alleviation
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pain Management Therapeutics Market, by Drug Class
8.1. Introduction
8.2. Adjuvant Analgesics
8.3. Local Anesthetics
8.4. Neuropathic Pain Agents
8.4.1. Anticonvulsants
8.4.2. Antidepressants
8.5. Nonsteroidal Anti-Inflammatory Drugs
8.5.1. Cox-2 Inhibitors
8.5.2. Traditional NsaiDs
8.6. Opioids
8.6.1. Strong Opioids
8.6.2. Weak Opioids
9. Pain Management Therapeutics Market, by Route Of Administration
9.1. Introduction
9.2. Oral
9.3. Parenteral
9.3.1. Intramuscular
9.3.2. Intravenous
9.3.3. Subcutaneous
9.4. Topical
9.5. Transdermal
10. Pain Management Therapeutics Market, by Indication
10.1. Introduction
10.2. Acute Pain
10.3. Cancer Pain
10.4. Chronic Pain
10.4.1. Low Back Pain
10.4.2. Neuropathic Chronic Pain
10.4.3. Osteoarthritis
10.4.4. Rheumatoid Arthritis
10.5. Inflammatory Pain
10.6. Neuropathic Pain
11. Pain Management Therapeutics Market, by Distribution Channel
11.1. Introduction
11.2. Offline
11.3. Online
12. Pain Management Therapeutics Market, by End User
12.1. Introduction
12.2. Ambulatory Surgical Centers
12.3. Home Care Settings
12.3.1. Hospice Care
12.3.2. Patient Home
12.4. Hospitals
12.4.1. Private Hospitals
12.4.2. Public Hospitals
13. Americas Pain Management Therapeutics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Pain Management Therapeutics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Pain Management Therapeutics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Johnson & Johnson
16.3.2. Pfizer Inc.
16.3.3. Novartis AG
16.3.4. Bayer AG
16.3.5. GlaxoSmithKline plc
16.3.6. Sanofi S.A.
16.3.7. Teva Pharmaceutical Industries Ltd.
16.3.8. Endo International plc
16.3.9. Mallinckrodt plc
16.3.10. AstraZeneca plc
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. PAIN MANAGEMENT THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. PAIN MANAGEMENT THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. PAIN MANAGEMENT THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. PAIN MANAGEMENT THERAPEUTICS MARKET: RESEARCHAI
FIGURE 26. PAIN MANAGEMENT THERAPEUTICS MARKET: RESEARCHSTATISTICS
FIGURE 27. PAIN MANAGEMENT THERAPEUTICS MARKET: RESEARCHCONTACTS
FIGURE 28. PAIN MANAGEMENT THERAPEUTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PAIN MANAGEMENT THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ADJUVANT ANALGESICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ADJUVANT ANALGESICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOCAL ANESTHETICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN AGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN AGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN AGENTS, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN AGENTS, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COX-2 INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COX-2 INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY TRADITIONAL NSAIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY TRADITIONAL NSAIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY STRONG OPIOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY STRONG OPIOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY WEAK OPIOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY WEAK OPIOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY PARENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY TRANSDERMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ACUTE PAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ACUTE PAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CANCER PAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CANCER PAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC PAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOW BACK PAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY LOW BACK PAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC CHRONIC PAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC CHRONIC PAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OSTEOARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OSTEOARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC PAIN, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC PAIN, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INFLAMMATORY PAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INFLAMMATORY PAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPICE CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPICE CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY PATIENT HOME, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY PATIENT HOME, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN AGENTS, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN AGENTS, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC PAIN, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC PAIN, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN AGENTS, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN AGENTS, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC PAIN, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC PAIN, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 155. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 156. UNITED STATES PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 157. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 158. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 159. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN AGENTS, 2018-2024 (USD MILLION)
TABLE 160. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN AGENTS, 2025-2030 (USD MILLION)
TABLE 161. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 162. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 163. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2018-2024 (USD MILLION)
TABLE 164. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2025-2030 (USD MILLION)
TABLE 165. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 166. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 167. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 168. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 169. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 170. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 171. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC PAIN, 2018-2024 (USD MILLION)
TABLE 172. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC PAIN, 2025-2030 (USD MILLION)
TABLE 173. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 176. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 177. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 178. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 179. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 180. CANADA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 181. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 182. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 183. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN AGENTS, 2018-2024 (USD MILLION)
TABLE 184. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN AGENTS, 2025-2030 (USD MILLION)
TABLE 185. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 186. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 187. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2018-2024 (USD MILLION)
TABLE 188. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2025-2030 (USD MILLION)
TABLE 189. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 190. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 191. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 192. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 193. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 194. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 195. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC PAIN, 2018-2024 (USD MILLION)
TABLE 196. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC PAIN, 2025-2030 (USD MILLION)
TABLE 197. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 200. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 201. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 202. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 203. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 204. MEXICO PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN AGENTS, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN AGENTS, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC PAIN, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC PAIN, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN AGENTS, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN AGENTS, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC PAIN, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC PAIN, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN AGENTS, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN AGENTS, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC PAIN, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC PAIN, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOME CARE SETTINGS, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN AGENTS, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NEUROPATHIC PAIN AGENTS, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY NONSTEROIDAL ANTI-INFLAMMATORY DRUGS, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY OPIOIDS, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC PAIN, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY CHRONIC PAIN, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE, BY HOME CARE SETTINGS, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM PAIN MANAGEMENT THERAPEUTICS MARKET SIZE

Samples

Loading
LOADING...

Companies Mentioned

  • Johnson & Johnson
  • Pfizer Inc.
  • Novartis AG
  • Bayer AG
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • Teva Pharmaceutical Industries Ltd.
  • Endo International plc
  • Mallinckrodt plc
  • AstraZeneca plc

Table Information

Report AttributeDetails
No. of Pages198
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 90.67 Billion
Forecasted Market Value ( USD ) by 2030 $ 114.41 Billion
Compound Annual Growth Rate4.7%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Non-opioid Pain Patches Market by Technology (Acrylic Adhesive, Hydrogel Adhesive, Silicone Adhesive), Application (Acute Pain, Chronic Pain), Product Type, End User, Distribution Channel, Drug Type - Global Forecast 2025-2030 - Product Image

Non-opioid Pain Patches Market by Technology (Acrylic Adhesive, Hydrogel Adhesive, Silicone Adhesive), Application (Acute Pain, Chronic Pain), Product Type, End User, Distribution Channel, Drug Type - Global Forecast 2025-2030

  • Report
  • 198 Pages
  • Global
From
Neuropathic Pain Drug Market by Product Type (Anticonvulsants, Antidepressants, Opioids), Route Of Administration (Intravenous, Oral, Topical), Indication, Distribution Channel - Global Forecast 2025-2030 - Product Image

Neuropathic Pain Drug Market by Product Type (Anticonvulsants, Antidepressants, Opioids), Route Of Administration (Intravenous, Oral, Topical), Indication, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 187 Pages
  • Global
From
Non-Opioids Analgesics Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Image

Non-Opioids Analgesics Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • 186 Pages
  • Global
From
Acute Pain- Pipeline Insight, 2025 - Product Image

Acute Pain- Pipeline Insight, 2025

  • Drug Pipelines
  • 80 Pages
  • Global
From
Chronic Pain Market Report 2025 - Product Image

Chronic Pain Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Pain Management Market

The Pain Management market within the context of Analgesics is a large and diverse field. It includes a variety of products and services designed to reduce or eliminate pain. These products and services range from over-the-counter medications to prescription drugs, physical therapy, and alternative treatments. Analgesics are a type of medication used to reduce or eliminate pain. They can be divided into two main categories: non-opioid analgesics, such as ibuprofen and acetaminophen, and opioid analgesics, such as morphine and oxycodone. Non-opioid analgesics are generally considered to be safer and more effective than opioid analgesics, but they are not as effective at treating severe pain. The Pain Management market is highly competitive, with many companies offering a variety of products and services. Some of the major players in the market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Merck, Novartis, and Eli Lilly. Other companies in the market include Teva Pharmaceuticals, Mylan, and Endo Pharmaceuticals. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.